Yanzhi Li Selected Research

Yanzhi Li Research Topics

2	Neoplasms (Cancer) 04/2021 - 08/2018
1	Poisoning 08/2022
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 04/2021
1	Infertility (Sterility) 04/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Breast Neoplasms (Breast Cancer) 08/2018
1	Cognitive Dysfunction 09/2017
1	Hyperlipidemias (Hyperlipidemia) 03/2015
1	Inflammation (Inflammations) 01/2011
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2011
1	Hypertrophy 01/2010
1	Hypercholesterolemia 01/2010
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2010
1	Cardiomegaly (Heart Hypertrophy) 01/2010

2	LipidsIBA 03/2015 - 01/2010
2	Rosiglitazone (Avandia)FDA Link 01/2011 - 01/2010
1	ZeolitesIBA 08/2022
1	PlatinumIBA 08/2022
1	cetrorelix (Cetrotide)FDA Link 04/2021
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 04/2021
1	Hormones (Hormone)IBA 04/2021
1	Uric Acid (Urate)IBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2018
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2017
1	Liposomes (Liposome)IBA 03/2015
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2011
1	Surface-Active Agents (Surfactants)IBA 01/2011
1	CholesterolIBA 01/2010
1	Type 1 Angiotensin ReceptorIBA 01/2010
1	PPAR gammaIBA 01/2010
1	Angiotensin IIIBA 01/2010
1	Irbesartan FDA LinkGeneric 01/2010
1	LigandsIBA 01/2010